ID: ALA4069697

Max Phase: Preclinical

Molecular Formula: C38H45N2O7P

Molecular Weight: 672.76

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(CCCC(=O)c2ccc(COC[C@@](C)(N)COP(=O)(N[C@@H](C)C(=O)OCc3ccccc3)Oc3ccccc3)cc2)cc1

Standard InChI:  InChI=1S/C38H45N2O7P/c1-29-17-19-31(20-18-29)13-10-16-36(41)34-23-21-33(22-24-34)25-44-27-38(3,39)28-46-48(43,47-35-14-8-5-9-15-35)40-30(2)37(42)45-26-32-11-6-4-7-12-32/h4-9,11-12,14-15,17-24,30H,10,13,16,25-28,39H2,1-3H3,(H,40,43)/t30-,38+,48?/m0/s1

Standard InChI Key:  ULYWBKFVIGPTLU-ZVAFOHNYSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 672.76Molecular Weight (Monoisotopic): 672.2964AlogP: 7.36#Rotatable Bonds: 19
Polar Surface Area: 126.18Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.33CX Basic pKa: 9.49CX LogP: 6.68CX LogD: 4.86
Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.06Np Likeness Score: -0.29

References

1. James E, Pertusati F, Brancale A, McGuigan C..  (2017)  Kinase-independent phosphoramidate S1P1 receptor agonist benzyl ether derivatives.,  27  (6): [PMID:28236593] [10.1016/j.bmcl.2017.02.011]

Source